Video: How cancer spreads
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - August 7, 2018 Category: Consumer Health News Source Type: news

Chemotherapy found to stop new brain cells from growing, worsening depression in brain cancer patients
(Natural News) Chemotherapy is depressing enough, but a drug used in the procedure may heighten it and make it worse, according to a study by researchers from King’s College London. Depression is considered one of the least recognizable symptoms of cancer since the condition is commonly attributed to the shock of the patient upon hearing... (Source: NaturalNews.com)
Source: NaturalNews.com - August 6, 2018 Category: Consumer Health News Source Type: news

Researchers Find New Mesothelioma Genes in Family Study
This study strengthens the suspicion that, next to germline BAP1 alterations, other genetic factors might predispose families to the development of MM,” the authors wrote. Mutations in only one gene called BAP1 have been shown to increase risk of mesothelioma. However, experts suspect other genes may play a role in the disease. This new study supports the idea that other genes can predispose a person — or even an entire family — to mesothelioma. Hints of Genetic Influence on Mesothelioma Risk Asbestos exposure is the No. 1 cause of mesothelioma. However, some families seem to have more cases of mesothe...
Source: Asbestos and Mesothelioma News - August 6, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Scout Marks the Spot in Soft Tissue for Cancer Treatment
Cianna Medical celebrated another regulatory milestone this week after FDA cleared its Scout reflector for an extended indication, allowing the tiny device to be used to mark soft tissue sites, including lymph nodes.  The non-radioactive wire-free localization device is smaller than a grain of rice (4mm) and won the gold award in the 2017 Medical Device Excellence Awards for the category of ER and OR tools, equipment, and supplies. Last year FDA cleared the device for implantation in breast cancer patients without restrictions on the length of time that it can remain in the breast. The reflector is completely p...
Source: MDDI - August 6, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Implants Source Type: news

Man survives internal decapitation years after beating brain cancer
Brock Meister, 22, of Plymouth, Indiana, beat incredible odds and survived an internal decapitation in January, which is when the skull separates from the spinal cord. (Source: the Mail online | Health)
Source: the Mail online | Health - August 6, 2018 Category: Consumer Health News Source Type: news

Temple hires financial advisor as it explores possible sale of 2 hospitals
Temple University announced Monday it has retained the services of Juniper Advisory to pursue strategic options for Temple University Health System, which include the possible sale of Fox Chase Cancer Center, neighboring Jeanes Hospital or both.   The move comes about a month-and-a-half after Temple's Board of Trustees announced it had authorized a series of steps aimed at strengthening the health system's finances and "preserve its ability to serve its mission." One of those steps was authorizing… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 6, 2018 Category: American Health Authors: John George Source Type: news

Temple hires financial advisor as it explores possible sale of 2 hospitals
Temple University announced Monday it has retained the services of Juniper Advisory to pursue strategic options for Temple University Health System, which include the possible sale of Fox Chase Cancer Center, neighboring Jeanes Hospital or both.   The move comes about a month-and-a-half after Temple's Board of Trustees announced it had authorized a series of steps aimed at strengthening the health system's finances and "preserve its ability to serve its mission." One of those steps was authorizing… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 6, 2018 Category: Biotechnology Authors: John George Source Type: news

Combined Digital Screening Best for Detecting Breast Cancers
MONDAY, Aug. 6, 2018 -- The combination of digital mammography (DM) and digital breast tomosynthesis (DBT) detects 90 percent more breast cancers than digital mammography alone, according to a study published in the August issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 6, 2018 Category: Pharmaceuticals Source Type: news

Cancer warning: Nine of the most common signs and symptoms of cancer - are you at risk?
CANCER symptoms usually include any unexplained changes to the body, such as weight loss or lumps. But, how are you supposed to know if you ’re at risk of the deadly disease? These are the most common signs of cancer. Speak to a doctor if you have any of these symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - August 6, 2018 Category: Consumer Health News Source Type: news

Preview the new $32 million cancer center Orlando Health built in Ocoee
The center will be one of six centers in the country that features a $6.5 million MRIdian System. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2018 Category: Pharmaceuticals Authors: Ryan Lynch Source Type: news

Libyan cancer clinic relies on donors to treat patients
One of Libya's few cancer clinics is relying on donors to keep its doors open for patients who often travel hundreds of kilometers (miles) for life-saving treatment. (Source: Reuters: Health)
Source: Reuters: Health - August 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FIT Outreach Increased Colon Cancer Screening
(MedPage Today) -- Modest success in mailing fecal immunochemical tests directly to homes (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 6, 2018 Category: Gastroenterology Source Type: news

Biomarker Panel May Improve Lung Cancer Risk Assessment
Risk score based on panel of four circulating protein biomarkers (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 6, 2018 Category: Respiratory Medicine Tags: Oncology, Pathology, Pulmonology, Radiology, Journal, Source Type: news

Provider factors influence breast cancer screening
Variations among women in breast cancer screening are due to provider and health...Read more on AuntMinnie.comRelated Reading: Shared decision-making for mammography could be clearer Radiologist factors influence mammography recall rates Geographic factors affect mammography uptake Mammography screening should consider radiation risk Would risk-based breast screening be more cost-effective? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 6, 2018 Category: Radiology Source Type: news

Plymouth Meeting-based Inovio teams up with AIDS Malignancy Consortium for immunotherapy study
Inovio Pharmaceuticals, Inc. has entered into a partnership with the AIDS Malignancy Consortium to evaluate VGX-3100 as a potential therapy for HIV-positive adult men and women. The Plymouth Meeting, Pa., biopharmaceutical company is developing VGX-3100, an immunotherapy designed to boost the ability of person's immune system to fight diseases, as a treatment for human papillomavirus (HPV)-associated precancerous conditions. Under the terms of the partnership, the consor tium will fund a mid-stage… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

Increased risk of cancer from breast implants? Woman barely survives rare blood cancer linked to her implants
(Natural News) A 48-year-old British woman survived a rare blood cancer that was triggered by her breast implants. Known as anaplastic large cell lymphoma (ALCL), this type of cancer is said to be a result of a reaction between the white blood cells and the new generation of rough surfaced breast implants introduced a decade... (Source: NaturalNews.com)
Source: NaturalNews.com - August 6, 2018 Category: Consumer Health News Source Type: news

Robotic vs Open Surgery for Prostatectomy: Which Wins? Robotic vs Open Surgery for Prostatectomy: Which Wins?
Randomized comparison of robot-assisted vs open radical prostatectomy shows similar functional outcomes, but oncologic outcomes require'cautious interpretation. 'Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 6, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Kris:'Don't Be Afraid to Use the Word & quot;Cure & quot; When It's Possible'Kris:'Don't Be Afraid to Use the Word & quot;Cure & quot; When It's Possible '
Can we reimagine cancer treatment to cure patients? Dr Mark Kris discusses this major theme from ASCO 2018.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 6, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Cardiac Surveillance in Breast Cancer Survivors Who Received IMC Radiation?
Internal mammary chain radiation therapy for breast cancer is associated with increased cardiac toxicity, in particular when paired with anthracyclines. (Source: CancerNetwork)
Source: CancerNetwork - August 6, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Rick Turner obituary
Archaeologist who recovered Lindow Man, the best preserved bog body in BritainRick Turner, who has died aged 66 of cancer, made the archaeological discovery of the 1980s when he recovered Lindow Man, the best preserved bog body in Britain. The find, in 1984, helped to pioneer new techniques of investigation and analysis, and provided fresh insight into how our ancestors lived.As county archaeologist for Cheshire, Rick was called out to the Lindow Moss peat bog near Wilmslow by the police when a human foot was found by a worker at a commercial peat cutting site. An incomplete and decomposing female head had been discovered ...
Source: Guardian Unlimited Science - August 6, 2018 Category: Science Authors: Jonathan Berry Tags: Archaeology British Museum Science Wales Conservation Source Type: news

Cytoreductive Nephrectomy May Still Remain Standard For Some With Metastatic Renal Cell Carcinoma
The addition of cytoreductive nephrectomy to treatment with sunitinib malate did not provide a survival benefit for intermediate and poor-risk patients with metastatic renal cell carcinoma, according to results of the phase 3 CARMENA clinical trial presented at ASCO Annual Meeting.08/06/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 6, 2018 Category: Urology & Nephrology Source Type: news

Kidney Cancer Association earns 4-star rating from Charity Navigator for fourth consecutive year
The Kidney Cancer Association ’s strong financial health and commitment to accountability and transparency has earned it a 4-star rating from Charity Navigator, America’s largest independent charity evaluator. “People can donate to our charity with confidence. We scored 100 percent in accountability and transparency,” s aid Bill Bro, vice president of the Kidney Cancer Association. Since 2002, using objective analysis, Charity Navigator has awarded only the most fiscally responsible organizations a 4-star rating. In 2011, Charity Navigator added 17 metrics, focused on governance and ethical practi...
Source: Kidney Cancer Association - August 6, 2018 Category: Urology & Nephrology Source Type: news

P & G manager, St. Elizabeth doctor band together to battle cancer
When Procter& Gamble Co. manager Brian Lauer was undergoing treatment for stomach cancer, he learned that his love of music was shared by his doctor at St. Elizabeth Healthcare.   Both men have side gigs in local bands, which prompted Lauer and Dr. Dan Flora to organize a music festival that will be held this weekend to raise funds in support of Northern Kentucky families coping with cancer.  The Bands Against Cancer festival sponsored by St. Elizabeth will run from 2:3 0 to 11:30 p.m. Aug. 11… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2018 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

Varian Medical acquires radiation therapy patient management system dev HumediQ
Varian Medical (NYSE:VAR) said today it acquired privately-held HumediQ, which develops the Identify automated patient identification, positioning and management system for radiation therapy, for an undisclosed amount. Palo Alto, Calif.-based Varian said the acquisition was made to expand its motion-management portfolio as part of its “long-term growth and value creation strategy.” “Varian is focused on enabling sophisticated high-quality cancer care safely and effectively, around the globe. Varian and HumediQ Global share a common mission in the worldwide fight against cancer and we are pleased to w...
Source: Mass Device - August 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Varian Medical Systems Source Type: news

Going Through the Motions
If the pharma industry got a dollar for every time it talked about improving relationships with payers, it probably wouldn ’t have a grave pricing challenge on its hands.Looking at it rationally, there is a clear win-win from greater harmony – pharma understands in advance the concerns of payers and can adjust its strategy to ensure effective market access, while payers get a heads-up on drugs are coming through and what impact they will have, and can plan budgets ahead.Yet, the reality is somewhat different. Collaboration – the word de jour for pharma in this decade – does not come easily, and many...
Source: EyeForPharma - August 6, 2018 Category: Pharmaceuticals Authors: Adam Chapman Source Type: news

OncoSec inks research deal to analyze clinical trial participants
OncoSec Medical (NSDQ:ONCS) said today that it inked a research deal with Dr. Roger Lo and his research team at the University of California Los Angeles to study participants from the biotech company’s Pisces/Keynote-695 Phase IIb clinical trial. Dr. Lo and his team are slated to perform genetic, transcriptomic and methylomic analyses of patients from OncoSec’s melanoma trial, which is focused on the intra-tumoral delivery of tavokinogene telseplasmid combined with Merck‘s (NYSE:MRK) Keytruda for people with metastatic melanoma. Get the full story at our sister site, Drug Delivery Busi...
Source: Mass Device - August 6, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Pharmaceuticals Research & Development Wall Street Beat OncoSec Medical Source Type: news

Biomarker Panel May Improve Lung Cancer Risk Assessment
MONDAY, Aug. 6, 2018 -- Biomarker-based risk profiling has the potential to improve lung cancer risk assessment, according to a study published online July 12 in JAMA Oncology. Florence Guida, Ph.D., from the International Agency for Research on... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 6, 2018 Category: Pharmaceuticals Source Type: news

Children are overexposed to plastic chemicals
The American Academy of Pediatrics recommends that parents limit their use of plastic containers and cut down on processed food, to reduce the risk of obesity and cancer in children.Independent (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 6, 2018 Category: Endocrinology Source Type: news

New hormonal mechanism implicated in pancreatic cancer progression
A high-fat diet may predispose to pancreatic cancer through direct interaction with hormone cholecystokinin, rather than obesity-related mechanisms, according to research published in theAmerican Journal of Physiology - Gastrointestinal and Liver Physiology. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 6, 2018 Category: Endocrinology Source Type: news

Regeneron to invest $100 million in bluebird, jointly develop cancer therapies
Regeneron Pharmaceuticals Inc said on Monday it will invest $100 million in cancer drug developer bluebird bio Inc, and the companies will jointly develop new cell therapies for cancer. (Source: Reuters: Health)
Source: Reuters: Health - August 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Here we go again: Michigan declares state of emergency after cancer-causing chemical confirmed in the public water supply
(Natural News) The state of Michigan has declared a local state of emergency in the city of Parchment after high levels of toxic perfluoroalkyl and polyfluoroalkyl substances (PFAS) were found in the municipal water source there. On July 26, residents were told to stop drinking water after tests showed that the city’s water supply had... (Source: NaturalNews.com)
Source: NaturalNews.com - August 6, 2018 Category: Consumer Health News Source Type: news

How ablation destroys cancer to prolong lives
Ablation, a minimally invasive tumour-destroying technique using focused radiation, is proving effective. So why is it not more widely known?Seven years ago, when Heather Hall was informed by her oncologist that her kidney cancer had spread to the liver, she initially assumed she had just months to live. “I’d been on chemotherapy for a while, but they’d done a CT scan and found three new tumours,” she says. “But they then said that, because the tumours were relatively small, they could try to lengthen my prognosis by removing them with ablation.”Hall underwent a course of microwave ablat...
Source: Guardian Unlimited Science - August 6, 2018 Category: Science Authors: David Cox Tags: Cancer research Health & wellbeing Medical research Science Life and style Source Type: news

Regeneron And Bluebird Team Up To Invent New Cell Therapies For Cancer
Regeneron Pharmaceuticals, one of the largest biotechnology companies, and gene therapy upstart Bluebird Bio will team up to invent genetically modified white blood cells that can attack cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 6, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:REGN NASDAQ:BLUE Source Type: news

Regeneron And Bluebird Team To Invent New Cell Therapies For Cancer
Regeneron Pharmaceuticals, one of the largest biotechnology companies, and gene therapy upstart Bluebird Bio will team up to invent genetically modified white blood cells that can attack cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 6, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:REGN NASDAQ:BLUE Source Type: news

Suicide risk among lung cancer patients in Lithuania - Kaceniene A, Danila E, Cicenas S, Smailyte G.
Several large cancer registry data based studies have demonstrated an increased risk of suicide among cancer patients compared with the general population.[1] The majority of studies reported that cancers of the lung generally carry the highest rates of pa... (Source: SafetyLit)
Source: SafetyLit - August 6, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Tramadol use in Norway: a register-based population study - Birke H, Ekholm O, Sj øgren P, Fredheim O, Clausen T, Skurtveit S.
PURPOSE: Increasing use of tramadol for chronic non-cancer pain is concerning since tramadol users may be at risk of developing recurrent opioid use with increasing opioid consumption and co-medication. Therefore, we investigated a complete national cohort... (Source: SafetyLit)
Source: SafetyLit - August 6, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

My IVF life: the science experiment to make a baby – from a partner's view
E, Jean Hannah Edelstein ’s husband, explains his side of IVF treatment, from the sperm analysis to the importance of patienceWhat ’s it like to be the partner of someone going through IVF treatment? This week, I sat down to discuss the experience with my husband, E. Like me, E is in his mid-30s and has never had kids before. Here’s what he told me.We discussed IVF very early in our relationship – it’s been with us basically from the beginning. On our first date we talked about cancer in our families – I lost my mom about a year before you lost your dad, you told me about Lynch syndrome ...
Source: Guardian Unlimited Science - August 6, 2018 Category: Science Authors: Jean Hannah Edelstein Tags: Family Pregnancy Life and style Sex Parents and parenting Health & wellbeing Source Type: news

Bowel cancer symptoms: Four signs to look out for when you go to the toilet
BOWEL cancer symptoms are not always easy to spot as they can be mistaken for less serious health conditions. Many of the signs are linked to changes in bowel habit, but there are four things in particular you should check for when you go to the toilet. (Source: Daily Express - Health)
Source: Daily Express - Health - August 6, 2018 Category: Consumer Health News Source Type: news

Ask What Are the First Signs of Brain Cancer
What Are the First Signs of Brain Cancer? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 6, 2018 Category: General Medicine Source Type: news

The Dark Side of Sunless Tanning
Title: The Dark Side of Sunless TanningCategory: Health NewsCreated: 8/3/2018 12:00:00 AMLast Editorial Review: 8/6/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 6, 2018 Category: Cancer & Oncology Source Type: news

Progressive Care Integrates with Illinois Cancer Specialists to Join The US Oncology Network
Chicago, Illinois (August 6, 2018) – Illinois Cancer Specialists (ICS), an affiliate of The US Oncology Network (The Network), announced today that Progressive Care has joined its practice. The combined practice will continue to offer comprehensive, state-of-the-art cancer care in its nine convenien... (Source: McKesson News)
Source: McKesson News - August 6, 2018 Category: Information Technology Source Type: news

Medical News Today: New drug may improve liver cancer therapy
Hepatocellular carcinoma (liver cancer) is fast growing, has poor survival rates, and has inefficient current treatments. Can they be improved? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 6, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Strongly worded PET/CT reports influence follow-up
When radiologists use strong, specific follow-up recommendations in FDG-PET/CT...Read more on AuntMinnie.comRelated Reading: Breast cancer follow-up imaging varies widely Second opinions change half of breast imaging results Do radiologists call clinicians too often? Yes and no For the patient's sake, radiology reports must be clear Radiologists' expertise cuts inappropriate imaging (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 6, 2018 Category: Radiology Source Type: news

Update on Atypical Ductal Hyperplasia Update on Atypical Ductal Hyperplasia
Biomarkers indicating progression to carcinoma are needed for atypical ductal hyperplasia.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 6, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Epigenetic markers of ovarian cancer
(InSilico Medicine, Inc.) Insilico Medicine and its collaborators from Johns Hopkins and Insilico Medicine, used an integrated approach by coupling identification of genome-wide expression patterns in multiple cohorts of primary ovarian cancer samples and normal ovarian surface epithelium with innovative computational analysis of gene expression data, leading to the discovery of novel cancer-specific epigenetically silenced genes. The study reveals 43 genes abnormally methylated in ovarian cancer and identifies methylation of an engulfment gene, GULP1, as a potential biomarker of ovarian cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 6, 2018 Category: International Medicine & Public Health Source Type: news

Rapid diagnostic coupled with local therapy developed for brain tumors
(Brigham and Women's Hospital) Working together, researchers from Brigham and Women's Hospital (BWH) and neurosurgeons from Massachusetts General Hospital (MGH), along with colleagues at MIT, are designing a new, rapid molecular diagnostic and sustained release therapeutic that could be deployed during brain surgery to treat gliomas and prevent their return. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news

Study: Prioritize cardiac monitoring for high-risk breast cancer patients
(American College of Cardiology) Overall, heart failure is an uncommon complication of breast cancer treatment; however, the risk is higher in patients treated with certain types of chemotherapy and lower in younger patients, according to a study in a special 'Imaging in Cardio-oncology' issue of JACC: Cardiovascular Imaging. Researchers concluded that cardiac monitoring should be a higher priority for high-risk patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news

How common is endometrial cancer in women with postmenopausal bleeding?
(JAMA Network) Postmenopausal bleeding is a common symptom among most women with endometrial cancer but most women with   postmenopausal bleeding won't be diagnosed with endometrial cancer, findings that raise questions about how to best manage postmenopausal bleeding for the early detection of endometrial cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news

Mayo research team identifies genes that increase risk for triple-negative breast cancer
(Mayo Clinic) A research team led by Fergus Couch, Ph.D., a geneticist at Mayo Clinic, has identified specific genes associated with an increased risk for developing triple-negative breast cancer. Their research was published in the Journal of the National Cancer Institute. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news

MD Anderson and Jazz Pharmaceuticals collaborate to evaluate treatment options for hematol
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and Jazz Pharmaceuticals plc today announced a five-year collaboration agreement with a goal of evaluating therapies for multiple hematologic malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndromes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news